CAR Carclo plc
Carclo plc, together with its subsidiaries, operates as a plastics company in the United Kingdom, the rest of Europe, North America, and internationally. It operates in two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, such as sample tips and probe tips, cuvettes and multi-well components, single-use cartridges and assay consumables, and ancillary parts for automation and fluid handling; and components and assemblies for a range of drug delivery devices, including inhalers, auto-injectors and associated delivery systems. It also provides FusionCap, a vial closure concept; PureStop, a driving stopper engagement; GuardVial, a polymer vial; flight-control and low-stretch cables, streamline wires, and cable assembly and test; and CNC turning and milling, thread rolling, fixtures and small assemblies, and rapid specials for race programs. In addition, the company offers safety systems, arrestor gear ropes, inspection and life-cycle support, and rescue winch cables; and safety and security solutions. Carclo plc was incorporated in 1924 and is based in Mitcham, the United Kingdom.…
Industry Peers
Auto PartsKey Statistics
About Carclo (LON: CAR)
›
Carclo (LON: CAR) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Auto Parts industry, part of the Consumer Cyclical sector, and reports about 907 employees.
The shares were at 40.40 GBp on 19 November 2026, down 41.8% over 52 weeks.
At a market capitalisation of 29.66M GBP, it trades at 10.1 times trailing earnings and 5.7 times forward earnings. The median trailing P/E of its 17 largest Auto Parts peers is 19.7, a discount of 49% for CAR.
Carclo reports return on equity of -31.2%, an operating margin of 8.7% and revenue down 5.5% year over year.
Its debt exceeds its cash by 23.91M GBP. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 90.00 GBp is 122.8% above the current price.